Enalaprilat

angiotensinogen ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 17716647 Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE. 2007 Dec 22 1
2 17004021 The effect of sublingual captopril versus intravenous enalaprilat on angiotensin II plasma levels. 2006 Jun 1
3 11997320 Renal nerve stimulation augments effect of intraluminal angiotensin II on proximal tubule transport. 2002 Jun 1
4 11181415 The renal nerve is required for regulation of proximal tubule transport by intraluminally produced ANG II. 2001 Mar 2
5 10710136 The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm. 2000 Mar 1
6 11040233 Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension. 2000 Oct 1
7 10359736 Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries. 1999 Jun 8 3
8 9933831 Enalaprilat improves the impaired left ventricular pump function during exercise in hypertensives with coronary microangiopathy and with coronary artery disease. 1998 1
9 8770965 Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition. 1996 Jan 1
10 8874148 Analysis of responses to angiotensin I and angiotensin I-(3-10) in the mesenteric vascular bed of the cat. 1996 Aug 15 2
11 7769807 Continuous i.v. administration of the angiotensin-converting enzyme inhibitor enalaprilat in the critically ill: effects on regulators of circulatory homeostasis. 1995 Mar 1
12 8024040 Angiotensin I is converted to angiotensin II by a serine protease in human detrusor smooth muscle. 1994 Jun 3
13 7508047 Different effects of angiotensin-converting enzyme inhibition in human arteries and veins. 1993 2
14 8394785 Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions. 1993 Sep 1
15 1310484 Production of angiotensin-(1-7) by human vascular endothelium. 1992 Feb 1
16 1336190 Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor c-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate. 1992 Sep-Oct 1
17 1849639 Necrotizing tracheobronchitis (NTB) following high frequency ventilation: role of an angiotensin converting enzyme inhibitor. 1991 Jan-Feb 1
18 2172161 Determinants of angiotensin II generation during converting enzyme inhibition. 1990 Nov 2
19 2282472 Pharmacological evidence for the existence of a local renin-angiotensin system in porcine interlobar renal arteries. 1990 Sep 1
20 2476598 Cilazapril and enalapril inhibit local angiotensin I conversion in human veins but lack direct venodilating properties. 1989 Aug 1
21 2557432 Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. 1989 May 1
22 2831146 The ventrolateral medulla. A new site of action of the renin-angiotensin system. 1988 Feb 1
23 2852237 Regulation of regional vascular tone: the role of angiotensin conversion in human forearm resistance vessels. 1988 Dec 2
24 3023555 Enalaprilat: an intravenous substitute for oral enalapril therapy. Humoral and pharmacokinetic effects. 1986 Sep 1
25 3012004 Effects of enalaprilic acid on sodium excretion and renal hemodynamics in essential hypertension. 1985 Sep 1
26 6150096 Human angiotensin I competes with two non-thiol converting enzyme inhibitors (CGS 13934 & MK-422) to inhibit the angiotensin-converting enzyme activity of human plasma. 1984 Oct 2
27 6320208 Coronary vascular actions of the converting enzyme inhibitor, enalapril. 1984 Feb 1